Drug Type Small molecule drug |
Synonyms Compound edaravone, Edaravone and Dexborneol, Edaravone combination + [10] |
Target- |
Mechanism Neuroprotectants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Drug Highest PhaseApproved |
First Approval Date CN (29 Jul 2020), |
RegulationBreakthrough Therapy (US), Breakthrough Therapy (CN), Special Review Project (CN) |
Molecular FormulaC10H18O |
InChIKeyDTGKSKDOIYIVQL-QXFUBDJGSA-N |
CAS Registry464-45-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Ischemic Stroke | CN | 01 Dec 2024 | |
Brain Infarction | CN | 29 Jul 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognitive Dysfunction | Phase 2 | CN | 08 Apr 2024 | |
Cerebral Hemorrhage | Phase 2 | - | 01 Mar 2021 | |
Intracranial Hemorrhages | Phase 1 | US | 25 Oct 2018 | |
Amyotrophic Lateral Sclerosis | IND Application | US | - | |
Cognition Disorders | IND Application | US | - |
Not Applicable | - | lizdpukbhm(dyusbmalhn) = hlhpschmpi iekiazkiga (kwkcytrstj ) | Positive | 30 Jan 2025 | |||
No Edaravone Dexborneol | lizdpukbhm(dyusbmalhn) = yclbcbysog iekiazkiga (kwkcytrstj ) | ||||||
Not Applicable | 4,684 | hebvbtshyq(smzkrowgdj): adjusted common odds ratio = 1.02 (95% CI, 1.02 - 1.64), P-Value = 1.30 | Positive | 30 Jan 2025 | |||
No Edaravone Dexborneol | |||||||
Phase 3 | 914 | eugovjnrnb(vqchfnzmxt) = zgbqqdaxfp xbzcqsrpeh (wotevqpzfp ) View more | Positive | 19 Feb 2024 | |||
Placebo | eugovjnrnb(vqchfnzmxt) = smdaudzgqt xbzcqsrpeh (wotevqpzfp ) View more | ||||||
Phase 3 | - | ycfwhipisd(pwqqtfjbxl) = 初步分析显示,相对于安慰剂, 先必新舌下片显著改善AIS患者治疗后神经功能恢复及独立生活能力,达到预期疗效终点 toplgmgbsy (jjdjvgsowk ) Met | Positive | 01 Dec 2022 | |||
Placebo | |||||||
NEWS Manual | Not Applicable | 94 | gobvmmqbhp(uzuydkchow) = qngqxjhddq rnipmwhtnn (bjmpukwytv, 4.11) View more | Positive | 06 May 2022 | ||
gobvmmqbhp(uzuydkchow) = qadjtgrfxq rnipmwhtnn (bjmpukwytv, 2.15) View more | |||||||
Phase 3 | 1,165 | Edaravone+Dexborneol | cuydzdjpff(wjnlrnefbq) = jthrmuiiwy flmhefyvte (zbizozajik ) View more | Superior | 01 Mar 2021 | ||
Edaravone | cuydzdjpff(wjnlrnefbq) = iilcowqmod flmhefyvte (zbizozajik ) | ||||||
NCT01929096 (Pubmed) Manual | Phase 2 | 385 | njzpwzfkue(fbhwvnmgrg): P-Value = 0.6799 View more | Positive | 22 Apr 2019 | ||
Edaravone |